» Articles » PMID: 22739986

Anti-apoptotic Effects of Suppressor of Cytokine Signaling 3 and 1 in Psoriasis

Overview
Journal Cell Death Dis
Date 2012 Jun 29
PMID 22739986
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Because of their genetically determined capacity to respond to pro-inflammatory stimuli, keratinocytes have a crucial role in the pathogenesis of psoriasis. Upon IFN-γ and TNF-α exposure, psoriatic keratinocytes express exaggerated levels of inflammatory mediators, and show aberrant hyperproliferation and terminal differentiation. The thickening of psoriasic skin also results from a peculiar resistance of keratinocytes to cytokine-induced apoptosis. In this study, we investigated on the molecular mechanisms concurring to the resistance of psoriatic keratinocytes to cell death, focusing on the role having suppressor of cytokine signaling (SOCS)1 and SOCS3, two molecules abundantly expressed in IFN-γ/TNF-α-activated psoriatic keratinocytes, in sustaining anti-apoptotic pathways. We found that SOCS1 and SOCS3 suppress cytokine-induced apoptosis by sustaining the activation of the PI3K/AKT pathway in keratinocytes. The latter determines the activation of the anti-apoptotic NF-κB cascade and, in parallel, the inhibition of the pro-apoptotic BAD function in keratinocytes. For the first time, we report that phosphorylated AKT and phosphorylated BAD are strongly expressed in lesional psoriatic skin, compared with healthy or not lesional skin, and they strictly correlate to the high expression of SOCS1 and SOCS3 molecules in the psoriatic epidermis. Finally, the depletion of SOCS1 and SOCS3, as well as the chemical inactivation of PI3K activity in psoriatic keratinocytes, definitively unveils the role of PI3K/AKT cascade on the resistance of diseased keratinocytes to apoptosis.

Citing Articles

CARD14 signalosome formation is associated with its endosomal relocation and mTORC1-induced keratinocyte proliferation.

OSullivan P, Aidarova A, Afonina I, Manils J, Thurston T, Instrell R Biochem J. 2024; 481(18):1143-1171.

PMID: 39145956 PMC: 11555713. DOI: 10.1042/BCJ20240058.


SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation.

Morelli M, Madonna S, Albanesi C Front Immunol. 2024; 15:1393799.

PMID: 38975347 PMC: 11224294. DOI: 10.3389/fimmu.2024.1393799.


Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.

Sasaki M, Kato D, Murakami K, Yoshida H, Takase S, Otsubo T Nat Commun. 2024; 15(1):4770.

PMID: 38839769 PMC: 11153594. DOI: 10.1038/s41467-024-49063-w.


Prevalence and trends of contact sensitization in patients with psoriasis in Lithuania.

Rudzikaite-Fergize G, Senulyte A, Guobyte N, Jurenas A, Macejevska M, Grigaitiene J JAAD Int. 2024; 16:59-65.

PMID: 38774342 PMC: 11107226. DOI: 10.1016/j.jdin.2024.02.015.


Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins.

Cianciulli A, Calvello R, Porro C, Lofrumento D, Panaro M Cells. 2024; 13(6.

PMID: 38534350 PMC: 10968894. DOI: 10.3390/cells13060505.


References
1.
Albanesi C, De Pita O, Girolomoni G . Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol. 2007; 25(6):581-8. DOI: 10.1016/j.clindermatol.2007.08.013. View

2.
Madonna S, Scarponi C, Sestito R, Pallotta S, Cavani A, Albanesi C . The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic.... J Immunol. 2010; 185(4):2467-81. DOI: 10.4049/jimmunol.1001426. View

3.
Kokolakis G, Giannikaki E, Stathopoulos E, Avramidis G, Tosca A, Kruger-Krasagakis S . Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions. Br J Dermatol. 2011; 166(3):491-7. DOI: 10.1111/j.1365-2133.2011.10689.x. View

4.
van de Geijn G, Gits J, Touw I . Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J Leukoc Biol. 2004; 76(1):237-44. DOI: 10.1189/jlb.0104041. View

5.
Bai S, Liu H, Chen K, Eksarko P, Perlman H, Moore T . NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis. Arthritis Rheum. 2004; 50(12):3844-55. DOI: 10.1002/art.20680. View